ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC32861-5mg |
|
1982372-88-2 |
A-196
|
0 | C18H16Cl2N4 | |
GC32861-1mg |
|
1982372-88-2 |
A-196
|
0 | C18H16Cl2N4 | |
GC32861-10mM(1mLinDMSO) |
|
1982372-88-2 |
A-196
|
0 | C18H16Cl2N4 | |
GC32860-100mg |
|
1581270-11-2 |
RIP2 kinase inhibitor 2
|
0 | C21H28N4O4S | |
GC32860-50mg |
|
1581270-11-2 |
RIP2 kinase inhibitor 2
|
0 | C21H28N4O4S | |
GC32860-10mg |
|
1581270-11-2 |
RIP2 kinase inhibitor 2
|
0 | C21H28N4O4S | |
GC32860-5mg |
|
1581270-11-2 |
RIP2 kinase inhibitor 2
|
0 | C21H28N4O4S | |
GC32860-1mg |
|
1581270-11-2 |
RIP2 kinase inhibitor 2
|
0 | C21H28N4O4S | |
GC32860-10mM(1mLinDMSO) |
|
1581270-11-2 |
RIP2 kinase inhibitor 2
|
0 | C21H28N4O4S | |
GC32859-50mg |
|
17673-25-5 |
Phorbol (4β-Phorbol)
|
0 | C20H28O6 | |
GC32859-25mg |
|
17673-25-5 |
Phorbol (4β-Phorbol)
|
0 | C20H28O6 | |
GC32859-5mg |
|
17673-25-5 |
Phorbol (4β-Phorbol)
|
0 | C20H28O6 | |
GC32859-1mg |
|
17673-25-5 |
Phorbol (4β-Phorbol)
|
0 | C20H28O6 | |
GC32859-10mM(1mLinWater) |
|
17673-25-5 |
Phorbol (4β-Phorbol)
|
0 | C20H28O6 | |
GC32858-100mg |
|
792957-74-5 |
ER-000444793
|
0 | C23H18N2O2 | |
GC32858-50mg |
|
792957-74-5 |
ER-000444793
|
0 | C23H18N2O2 | |
GC32858-10mg |
|
792957-74-5 |
ER-000444793
|
0 | C23H18N2O2 | |
GC32858-5mg |
|
792957-74-5 |
ER-000444793
|
0 | C23H18N2O2 | |
GC32858-1mg |
|
792957-74-5 |
ER-000444793
|
0 | C23H18N2O2 | |
GC32858-10mM(1mLinDMSO) |
|
792957-74-5 |
ER-000444793
|
0 | C23H18N2O2 | |